Abstract |
Objectives: This study aims to investigate the function of the protein arginine methyltransferase 5 (PRMT5) and fibroblast growth factor receptor 3 (FGFR3)/Akt signaling axis in the epithelial-mesenchymal transition (EMT) of human lung cancer. Methods: The mRNA and protein expression levels of PRMT5, FGFR3, p-Akt, and EMT markers are determined by quantitative real-time PCR and Western blotting, respectively; the expression and localization of PRMT5, p-Akt, and proliferating cell nuclear antigen are detected by immunofluorescence; the human lung cancer cell proliferation is measured by MTS assay. Results: PRMT5 and FGFR3 are highly expressed in human lung cancer tissues and are closely related to lymphatic metastasis. Moreover, down-regulation of PRMT5 by lentivirus-mediated shRNAs or inhibition of PRMT5 by specific inhibitors attenuates FGFR3 expression, Akt phosphorylation, and lung cancer cell proliferation. Further studies show that silencing PRMT5 impairs EMT-related markers, including vimentin, collagen I, and β- catenin. Conversely, ectopic expression of PRMT5 increases FGFR3 expression, Akt phosphorylation, and EMT-related markers, suggesting that PRMT5 regulates metastasis probably through the FGFR3/Akt signaling axis. Conclusion: PRMT5/FGFR3/Akt signaling axis controls human lung cancer progression and metastasis and also implies that PRMT5 may serve as a prognostic biomarker and therapeutic candidate for treating lung cancer.
|
Authors | Yonghua Zheng, Jingjing Lu, Xiaoyan Hu, Xiaobiao Hu, Xiwen Gao, Jie Zhou |
Journal | Technology in cancer research & treatment
(Technol Cancer Res Treat)
2023 Jan-Dec
Vol. 22
Pg. 15330338231161139
ISSN: 1533-0338 [Electronic] United States |
PMID | 36927233
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Proto-Oncogene Proteins c-akt
- Receptor, Fibroblast Growth Factor, Type 3
- RNA, Small Interfering
- FGFR3 protein, human
- PRMT5 protein, human
- Protein-Arginine N-Methyltransferases
|
Topics |
- Humans
- Proto-Oncogene Proteins c-akt
(metabolism)
- Receptor, Fibroblast Growth Factor, Type 3
(genetics, metabolism)
- Lung Neoplasms
(pathology)
- Signal Transduction
(genetics)
- RNA, Small Interfering
(genetics)
- Protein-Arginine N-Methyltransferases
(genetics, metabolism)
|